Breaking News

Amgen Investing $550M in New Biomanufacturing Facility

Will create 355 new jobs at Holly Springs, NC site.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Amgen has unveiled plans to build a new $550 million biologics manufacturing facility in Holly Springs, NC, creating 355 jobs along the way. The new site in the Research Triangle area of North Carolina will bring a biologics drug substance manufacturing plant online to help the company continue to meet the production demands for its medicines.   “Amgen is investing in a technologically-advanced drug substance plant in North Carolina to support the expected increase in demand for our medicines,” ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters